With the gained understanding of 4E-BP1 phosphorylation and eIF4G overexpression in CLL, we wanted to test whether targeting the effects of these proteins would affect CLL viability and survival. The gene discussed is EIF4EBP1; the disease is B-cell chronic lymphocytic leukemia.